Plakoglobin-dependent regulation of keratinocyte apoptosis by Rnd3

Journal of Cell Science

Volumn 125, Issue 13, 2012, Pages 3202-3209

  Ryan, Katie R ^a   Lock, Frances E ^a,b   Heath, John K ^a   Hotchin, Neil A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Apoptosis; Desmosomes; Plakoglobin; Rho GTPases; Rnd3

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CISPLATIN; DESMOSOMAL CADHERIN; GUANOSINE TRIPHOSPHATASE; PLAKOGLOBIN; PROTEIN RND3; RHO FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL STRUCTURE; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY;

ADHERENS JUNCTIONS; AMIDES; APOPTOSIS; CELL COMMUNICATION; CELL LINE; CELL SURVIVAL; CISPLATIN; DESMOPLAKINS; DESMOSOMES; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; PYRIDINES; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 84866087012     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.101931     Document Type: Article

References (50)

1. Aberle, H., Bierkamp, C., Torchard, D., Serova, O., Wagner, T., Natt, E., Wirsching, J., Heidkämper, C., Montagna, M., Lynch, H. T. et al. (1995). The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc. Natl. Acad. Sci. USA 92, 6384-6388.
2. Acehan, D., Petzold, C., Gumper, I., Sabatini, D. D., Müller, E. J., Cowin, P. and Stokes, D. L. (2008). Plakoglobin is required for effective intermediate filament anchorage to desmosomes. J. Invest. Dermatol. 128, 2665-2675.
3. Akhtar, N., Hudson, K. R. and Hotchin, N. A. (2000). Co-localization of Rac1 and E- cadherin in human epidermal keratinocytes. Cell Adhes. Commun. 7, 465-476.
4. Bektic, J., Pfeil, K., Berger, A. P., Ramoner, R., Pelzer, A., Schäfer, G., Kofler, K., Bartsch, G. and Klocker, H. (2005). Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis. Prostate 64, 332-340.
5. Bierkamp, C., Schwarz, H., Huber, O. and Kemler, R. (1999). Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. Development 126, 371-381.
6. Boswell, S. A., Ongusaha, P. P., Nghiem, P. and Lee, S. W. (2007). The protective role of a small GTPase RhoE against UVB-induced DNA damage in keratinocytes. J. Biol. Chem. 282, 4850-4858.
7. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771.
8. Chen, J., Zhou, H., Li, Q., Qiu, M., Li, Z., Tang, Q., Liu, M., Zhu, Y., Huang, J., Lang, N. et al. (2011). Epigenetic modification of RhoE expression in gastric cancer cells. Oncol. Rep. 25, 173-180.
9. Chitaev, N. A. and Troyanovsky, S. M. (1997). Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J. Cell Biol. 138, 193-201.
10. Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A. and Olson, M. F. (2001). Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345.
11. Foster, R., Hu, K. Q., Lu, Y., Nolan, K. M., Thissen, J. and Settleman, J. (1996). Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol. Cell. Biol. 16, 2689-2699.
12. Fuchs, E. (2007). Scratching the surface of skin development. Nature 445, 834-842.
13. Gallicano, G. I., Kouklis, P., Bauer, C., Yin, M., Vasioukhin, V., Degenstein, L. and Fuchs, E. (1998). Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J. Cell Biol. 143, 2009-2022.
14. Garcia-Gras, E., Lombardi, R., Giocondo, M. J., Willerson, J. T., Schneider, M. D., Khoury, D. S. and Marian, A. J. (2006). Suppression of canonical Wnt/b-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J. Clin. Invest. 116, 2012-2021.
15. Godsel, L. M., Hsieh, S. N., Amargo, E. V., Bass, A. E., Pascoe-McGillicuddy, L. T., Huen, A. C., Thorne, M. E., Gaudry, C. A., Park, J. K., Myung, K. et al. (2005). Desmoplakin assembly dynamics in four dimensions: multiple phases differentially regulated by intermediate filaments and actin. J. Cell Biol. 171, 1045-1059.
16. Godsel, L. M., Dubash, A. D., Bass-Zubek, A. E., Amargo, E. V., Klessner, J. L., Hobbs, R. P., Chen, X. and Green, K. J. (2010). Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA. Mol. Biol. Cell 21, 2844-2859.
17. Goh, L. L. and Manser, E. (2010). The RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain. PLoS ONE 5, e12409.
18. Gottardi, C. J., Wong, E. and Gumbiner, B. M. (2001). E-cadherin suppresses cellular transformation by inhibiting b-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153, 1049-1060.
19. Guasch, R. M., Scambler, P., Jones, G. E. and Ridley, A. J. (1998). RhoE regulates actin cytoskeleton organization and cell migration. Mol. Cell. Biol. 18, 4761-4771.
20. Hakimelahi, S., Parker, H. R., Gilchrist, A. J., Barry, M., Li, Z., Bleackley, R. C. and Pasdar, M. (2000). Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J. Biol. Chem. 275, 10905-10911.
21. Henseleit, U., Zhang, J., Wanner, R., Haase, I., Kolde, G. and Rosenbach, T. (1997). Role of p53 in UVB-induced apoptosis in human HaCaT keratinocytes. J. Invest. Dermatol. 109, 722-727.
22. Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M. and Narumiya, S. (2000). Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57, 976-983.
23. Jaffe, A. B. and Hall, A. (2005). Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247-269.
24. Karnovsky, A. and Klymkowsky, M. W. (1995). Anterior axis duplication in Xenopus induced by the over-expression of the cadherin-binding protein plakoglobin. Proc. Natl. Acad. Sci. USA 92, 4522-4526.
25. Koster, M. I. and Roop, D. R. (2007). Mechanisms regulating epithelial stratification. Annu. Rev. Cell Dev. Biol. 23, 93-113.
26. Kowalczyk, A. P., Bornslaeger, E. A., Borgwardt, J. E., Palka, H. L., Dhaliwal, A. S., Corcoran, C. M., Denning, M. F. and Green, K. J. (1997). The amino- terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J. Cell Biol. 139, 773-784.
27. Lehman, T. A., Modali, R., Boukamp, P., Stanek, J., Bennett, W. P., Welsh, J. A., Metcalf, R. A., Stampfer, M. R., Fusenig, N., Rogan, E. M. et al. (1993). p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14, 833-839.
28. Liebig, T., Erasmus, J., Kalaji, R., Davies, D., Loirand, G., Ridley, A. and Braga, V. M. (2009). RhoE Is required for keratinocyte differentiation and stratification. Mol. Biol. Cell 20, 452-463.
29. Lippens, S., Hoste, E., Vandenabeele, P., Agostinis, P. and Declercq, W. (2009). Cell death in the skin. Apoptosis 14, 549-569.
30. Lock, F. E. and Hotchin, N. A. (2009). Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation. PLoS ONE 4, e8190.
31. McMullan, R., Lax, S., Robertson, V. H., Radford, D. J., Broad, S., Watt, F. M., Rowles, A., Croft, D. R., Olson, M. F. and Hotchin, N. A. (2003). Keratinocyte differentiation is regulated by the Rho and ROCK signaling pathway. Curr. Biol. 13, 2185-2189.
32. Müller, E. J., Williamson, L., Kolly, C. and Suter, M. M. (2008). Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J. Invest. Dermatol. 128, 501-516.
33. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A. and Yuan, J. (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98-103.
34. Niessen, C. M. (2007). Tight junctions/adherens junctions: basic structure and function. J. Invest. Dermatol. 127, 2525-2532.
35. Ongusaha, P. P., Kim, H. G., Boswell, S. A., Ridley, A. J., Der, C. J., Dotto, G. P., Kim, Y. B., Aaronson, S. A. and Lee, S. W. (2006). RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress. Curr. Biol. 16, 2466-2472.
36. Poch, E., Miñambres, R., Mocholí, E., Ivorra, C., Pérez-Aragó, A., Guerri, C., Pérez-Roger, I. and Guasch, R. M. (2007). RhoE interferes with Rb inactivation and regulates the proliferation and survival of the U87 human glioblastoma cell line. Exp. Cell Res. 313, 719-731.
37. Riento, K., Guasch, R. M., Garg, R., Jin, B. and Ridley, A. J. (2003). RhoE binds to ROCK I and inhibits downstream signaling. Mol. Cell. Biol. 23, 4219-4229.
38. Riento, K., Totty, N., Villalonga, P., Garg, R., Guasch, R. and Ridley, A. J. (2005). RhoE function is regulated by ROCK I-mediated phosphorylation. EMBO J. 24, 1170-1180.
39. Sebbagh, M., Renvoizé, C., Hamelin, J., Riché, N., Bertoglio, J. and Bréard, J. (2001). Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3, 346-352.
40. Shiina, H., Breault, J. E., Basset, W. W., Enokida, H., Urakami, S., Li, L. C., Okino, S. T., Deguchi, M., Kaneuchi, M., Terashima, M. et al. (2005). Functional Loss of the c-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res. 65, 2130-2138.
41. Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H. G., Reed, J. C., Nicholson, D. W., Alnemri, E. S. et al. (1999). Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292.
42. Thomason, H. A., Scothern, A., McHarg, S. and Garrod, D. R. (2010). Desmosomes: adhesive strength and signalling in health and disease. Biochem. J. 429, 419-433.
43. Thorlacius, K., Slotta, J. E., Laschke, M. W., Wang, Y., Menger, M. D., Jeppsson, B. and Thorlacius, H. (2006). Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury. J. Leukoc. Biol. 79, 923-931.
44. Vasioukhin, V., Bowers, E., Bauer, C., Degenstein, L. and Fuchs, E. (2001). Desmoplakin is essential in epidermal sheet formation. Nat. Cell Biol. 3, 1076-1085.
45. Villalonga, P., Guasch, R. M., Riento, K. and Ridley, A. J. (2004). RhoE inhibits cell cycle progression and Ras-induced transformation. Mol. Cell. Biol. 24, 7829-7840.
46. Walczak, H. and Krammer, P. H. (2000). The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256, 58-66.
47. Waschke, J., Spindler, V., Bruggeman, P., Zillikens, D., Schmidt, G. and Drenckhahn, D. (2006). Inhibition of Rho A activity causes pemphigus skin blistering. J. Cell Biol. 175, 721-727.
48. Wennerberg, K., Forget, M. A., Ellerbroek, S. M., Arthur, W. T., Burridge, K., Settleman, J., Der, C. J. and Hansen, S. H. (2003). Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. Curr. Biol. 13, 1106-1115.
49. Winn, R. A., Bremnes, R. M., Bemis, L., Franklin, W. A., Miller, Y. E., Cool, C. and Heasley, L. E. (2002). gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 21, 7497-7506.
50. Zhurinsky, J., Shtutman, M. and Ben-Ze'ev, A. (2000). Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin. Mol. Cell. Biol. 20, 4238-4252.